222 related articles for article (PubMed ID: 16867168)
1. Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteers.
Swart PJ; Krauwinkel WJ; Smulders RA; Smith NN
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):33-6. PubMed ID: 16867168
[TBL] [Abstract][Full Text] [Related]
2. Food does not affect the pharmacokinetics of solifenacin, a new muscarinic receptor antagonist: results of a randomized crossover trial.
Uchida T; Krauwinkel WJ; Mulder H; Smulders RA
Br J Clin Pharmacol; 2004 Jul; 58(1):4-7. PubMed ID: 15206986
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of solifenacin succinate in healthy young men.
Smulders RA; Krauwinkel WJ; Swart PJ; Huang M
J Clin Pharmacol; 2004 Sep; 44(9):1023-33. PubMed ID: 15317830
[TBL] [Abstract][Full Text] [Related]
4. Effect of age on the pharmacokinetics of solifenacin in men and women.
Krauwinkel WJ; Smulders RA; Mulder H; Swart PJ; Taekema-Roelvink ME
Int J Clin Pharmacol Ther; 2005 May; 43(5):227-38. PubMed ID: 15906588
[TBL] [Abstract][Full Text] [Related]
5. Open-label study of the safety and pharmacokinetics of solifenacin in subjects with hepatic impairment.
Kuipers M; Smulders R; Krauwinkel W; Hoon T
J Pharmacol Sci; 2006 Dec; 102(4):405-12. PubMed ID: 17170513
[TBL] [Abstract][Full Text] [Related]
6. Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.
Smulders RA; Kuipers ME; Krauwinkel WJ
Br J Clin Pharmacol; 2006 Aug; 62(2):210-7. PubMed ID: 16842396
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the inhibitory effect of ketoconazole on budesonide pharmacokinetics by separation of their time of administration.
Seidegård J
Clin Pharmacol Ther; 2000 Jul; 68(1):13-7. PubMed ID: 10945311
[TBL] [Abstract][Full Text] [Related]
8. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
9. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
Chancellor MB; Zinner N; Whitmore K; Kobashi K; Snyder JA; Siami P; Karram M; Laramée C; Capo' JP; Seifeldin R; Forero-Schwanhaeuser S; Nandy I
Clin Ther; 2008 Oct; 30(10):1766-81. PubMed ID: 19014833
[TBL] [Abstract][Full Text] [Related]
12. Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects.
Park JY; Kim KA; Shin JG; Lee KY
Br J Clin Pharmacol; 2004 Oct; 58(4):397-402. PubMed ID: 15373932
[TBL] [Abstract][Full Text] [Related]
13. Ketoconazole inhibits the clearance of the enantiomers of the antidepressant reboxetine in humans.
Herman BD; Fleishaker JC; Brown MT
Clin Pharmacol Ther; 1999 Oct; 66(4):374-9. PubMed ID: 10546921
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: a double-blind, placebo-controlled study.
Taekema-Roelvink ME; Swart PJ; Kuipers ME; Krauwinkel WJ; Visser N; Smulders RA
Clin Ther; 2005 Sep; 27(9):1403-10. PubMed ID: 16291413
[TBL] [Abstract][Full Text] [Related]
15. Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide.
Jakate AS; Roy P; Patel A; Abramowitz W; Persiani S; Wangsa J; Kapil R
Br J Clin Pharmacol; 2005 Nov; 60(5):498-507. PubMed ID: 16236040
[TBL] [Abstract][Full Text] [Related]
16. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
18. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.
Wesnes KA; Edgar C; Tretter RN; Bolodeoku J
Expert Opin Drug Saf; 2009 Nov; 8(6):615-26. PubMed ID: 19747069
[TBL] [Abstract][Full Text] [Related]
19. Solifenacin demonstrates high absolute bioavailability in healthy men.
Kuipers ME; Krauwinkel WJ; Mulder H; Visser N
Drugs R D; 2004; 5(2):73-81. PubMed ID: 15293866
[TBL] [Abstract][Full Text] [Related]
20. Solifenacin significantly improves all symptoms of overactive bladder syndrome.
Chapple CR; Cardozo L; Steers WD; Govier FE
Int J Clin Pract; 2006 Aug; 60(8):959-66. PubMed ID: 16893438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
